Literature DB >> 28033313

Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

Rose A Rudd, Puja Seth, Felicita David, Lawrence Scholl.   

Abstract

The U.S. opioid epidemic is continuing, and drug overdose deaths nearly tripled during 1999-2014. Among 47,055 drug overdose deaths that occurred in 2014 in the United States, 28,647 (60.9%) involved an opioid (1). Illicit opioids are contributing to the increase in opioid overdose deaths (2,3). In an effort to target prevention strategies to address the rapidly changing epidemic, CDC examined overall drug overdose death rates during 2010-2015 and opioid overdose death rates during 2014-2015 by subcategories (natural/semisynthetic opioids, methadone, heroin, and synthetic opioids other than methadone).* Rates were stratified by demographics, region, and by 28 states with high quality reporting on death certificates of specific drugs involved in overdose deaths. During 2015, drug overdoses accounted for 52,404 U.S. deaths, including 33,091 (63.1%) that involved an opioid. There has been progress in preventing methadone deaths, and death rates declined by 9.1%. However, rates of deaths involving other opioids, specifically heroin and synthetic opioids other than methadone (likely driven primarily by illicitly manufactured fentanyl) (2,3), increased sharply overall and across many states. A multifaceted, collaborative public health and law enforcement approach is urgently needed. Response efforts include implementing the CDC Guideline for Prescribing Opioids for Chronic Pain (4), improving access to and use of prescription drug monitoring programs, enhancing naloxone distribution and other harm reduction approaches, increasing opioid use disorder treatment capacity, improving linkage into treatment, and supporting law enforcement strategies to reduce the illicit opioid supply.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28033313     DOI: 10.15585/mmwr.mm655051e1

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  660 in total

1.  Trends and Outcomes of Cardiovascular Surgery in Patients With Opioid Use Disorders.

Authors:  Krish C Dewan; Karan S Dewan; Jay J Idrees; Suparna M Navale; Brad F Rosinski; Lars G Svensson; A Marc Gillinov; Douglas R Johnston; Faisal Bakaeen; Edward G Soltesz
Journal:  JAMA Surg       Date:  2019-03-01       Impact factor: 14.766

2.  Commentary on Hsu et al. (2017): A systems approach to improving health services for overdose in the hospital and across the continuum of care-an unmet need.

Authors:  Ingrid A Binswanger
Journal:  Addiction       Date:  2017-09       Impact factor: 6.526

3.  Premature mortality projections in the USA through 2030: a modelling study.

Authors:  Ana F Best; Emily A Haozous; Amy Berrington de Gonzalez; Pavel Chernyavskiy; Neal D Freedman; Patricia Hartge; David Thomas; Philip S Rosenberg; Meredith S Shiels
Journal:  Lancet Public Health       Date:  2018-07-21

4.  Race and Gender Are Associated with Opioid Dose Reduction Among Patients on Chronic Opioid Therapy.

Authors:  Michele Buonora; Hector R Perez; Moonseong Heo; Chinazo O Cunningham; Joanna L Starrels
Journal:  Pain Med       Date:  2019-08-01       Impact factor: 3.750

5.  The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015.

Authors:  Tanner Nassau; Alia Al-Tayyib; William T Robinson; Jennifer Shinefeld; Kathleen A Brady
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

6.  Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands.

Authors:  Yi Zheng; Samuel Obeng; Huiqun Wang; Abdulmajeed M Jali; Bharath Peddibhotla; Dwight A Williams; Chuanchun Zou; David L Stevens; William L Dewey; Hamid I Akbarali; Dana E Selley; Yan Zhang
Journal:  J Med Chem       Date:  2019-01-11       Impact factor: 7.446

7.  Associations Between Physical Pain, Pain Management, and Frequency of Nonmedical Prescription Opioid Use Among Young Adults: A Sex-specific Analysis.

Authors:  Tristan I Evans; Elliott J Liebling; Traci C Green; Scott E Hadland; Melissa A Clark; Brandon D L Marshall
Journal:  J Addict Med       Date:  2017 Jul/Aug       Impact factor: 3.702

8.  Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014-2018.

Authors:  Traci C Green; Corey Davis; Ziming Xuan; Alexander Y Walley; Jeffrey Bratberg
Journal:  Am J Public Health       Date:  2020-04-16       Impact factor: 9.308

9.  Impact of opioid use on health care utilization and survival in patients with newly diagnosed stage IV malignancies.

Authors:  Dylan Zylla; Grant Steele; Alice Shapiro; Sara Richter; Pankaj Gupta
Journal:  Support Care Cancer       Date:  2018-02-02       Impact factor: 3.603

10.  Assessing Spatial Relationships between Prescription Drugs, Race, and Overdose in New York State from 2013 to 2015.

Authors:  Phillip L Marotta; Tim Hunt; Louisa Gilbert; Elwin Wu; Dawn Goddard-Eckrich; Nabila El-Bassel
Journal:  J Psychoactive Drugs       Date:  2019-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.